B+
Bull case
25%
Probability
Target price
$1.65
Analysis reference price unavailable
Analysis 2026-09-10 · RankAlpha Sentiment Codex
OCGN
OcugenANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
FDA clearance, RMAT designation, multiple late-stage programs, a potential MENA licensing transaction, and runway into 2028 create several opportunities for de-risking and platform re-rating [#SEC-8K-2026-08-06].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Analyst estimate revisions, target changes, and post-earnings price-reaction evidence are unavailable in the packet.
Momentum
92
Value
41
Sentiment
77
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.15 · Bull $1.65 · Bear $0.65Analysis 2026-09-10; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-10 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $12.08
Why
Momentum92 · Δ7d -
Value41 · Δ7d -0.0
Sentiment77 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Analyst estimate revisions, target changes, and post-earnings price-reaction evidence are unavailable in the packet.
- • Convertible senior notes and future capital needs may create dilution or financing overhang.
- • The thesis remains dependent on binary clinical and regulatory execution.
Catalyst clock
2026-09-30
OCU410 Phase 3 initiation and RMAT-enabled regulatory path
Lead driver: Sentiment · See AI snapshot
Momentum
92
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
77
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 91.8 / Value 41.2 / Sentiment 77.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-10. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$1.15
Analysis reference price unavailable
Analysis 2026-09-10 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$0.65
Analysis reference price unavailable
Analysis 2026-09-10 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$466.28M
Beta
3.49
Shares Out
339.11M
P/E (TTM) · Derived
-6.1
P/S (TTM)
84.33
P/FCF (TTM) · Derived
-7.23
Rev YoY
+8.4%
EPS YoY
+45.3%
Gross Margin
+37.0%
Op Margin
-1112.9%
Net Debt
$14.57M
Current Ratio
0.80
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data